bosentan anhydrous has been researched along with dinoprostone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Anadol, AZ; Bayram, O; Dursun, A; Ercan, S | 1 |
| Bishop, A; Crome, R; Duggan, AE; Filipowicz, B; Hawkey, CJ; Hull, M; Knifton, A; Polak, J; Stack, W; Weber, C | 1 |
| Gillissen, A; Haag, S; Juergens, UR; Lamyel, F; Novak, N; Racké, K; Stöber, M; Uen, S; Vetter, H | 1 |
1 trial(s) available for bosentan anhydrous and dinoprostone
| Article | Year |
|---|---|
Protection against aspirin-induced human gastric mucosal injury by bosentan, a new endothelin-1 receptor antagonist.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bosentan; Cross-Over Studies; Dinoprostone; Double-Blind Method; Endothelin Receptor Antagonists; Gastric Mucosa; Humans; Male; Misoprostol; Receptor, Endothelin A; Sulfonamides | 1999 |
4 other study(ies) available for bosentan anhydrous and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Role of endogenous endothelin peptides in intestinal ischemia-reperfusion injury in rats.
Topics: Animals; Bosentan; Dinoprostone; Endothelin Receptor Antagonists; Endothelins; Female; Glycopeptides; Histocytochemistry; Intestinal Mucosa; Intestines; Ischemia; Leukotriene C4; Male; Peptides, Cyclic; Rats; Reperfusion Injury; Sulfonamides | 1998 |
Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Arachidonic Acid; Bosentan; Cell Line; Cell Separation; Dinoprostone; Endothelin B Receptor Antagonists; Fibroblasts; Humans; In Vitro Techniques; Inflammation; Interleukin-1beta; Lipoxygenase Inhibitors; Monocytes; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Necrosis Factor-alpha | 2008 |